1 Pharmaceutical Cannabis Market Overview

• 1.1 Product Overview and Scope of Pharmaceutical Cannabis
• 1.2 Pharmaceutical Cannabis Segment by Type
  • 1.2.1 Global Pharmaceutical Cannabis Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 THC-dominant
  • 1.2.3 CBD-dominant
  • 1.2.4 Balanced THC & CBD
• 1.3 Pharmaceutical Cannabis Segment by Application
  • 1.3.1 Global Pharmaceutical Cannabis Sales Comparison by Application: (2021-2027)
  • 1.3.2 Cancer
  • 1.3.3 Arthritis
  • 1.3.4 Migraine
  • 1.3.5 Epilepsy
  • 1.3.6 Others
• 1.4 Global Pharmaceutical Cannabis Market Size Estimates and Forecasts
  • 1.4.1 Global Pharmaceutical Cannabis Revenue 2016-2027
  • 1.4.2 Global Pharmaceutical Cannabis Sales 2016-2027
  • 1.4.3 Pharmaceutical Cannabis Market Size by Region: 2016 Versus 2021 Versus 2027

2 Pharmaceutical Cannabis Market Competition by Manufacturers

• 2.1 Global Pharmaceutical Cannabis Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Pharmaceutical Cannabis Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Pharmaceutical Cannabis Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Pharmaceutical Cannabis Manufacturing Sites, Area Served, Product Type
• 2.5 Pharmaceutical Cannabis Market Competitive Situation and Trends
  • 2.5.1 Pharmaceutical Cannabis Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Pharmaceutical Cannabis Players Market Share by Revenue
  • 2.5.3 Global Pharmaceutical Cannabis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Pharmaceutical Cannabis Retrospective Market Scenario by Region

• 3.1 Global Pharmaceutical Cannabis Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.2 Global Pharmaceutical Cannabis Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.3 North America Pharmaceutical Cannabis Market Facts & Figures by Country
  • 3.3.1 North America Pharmaceutical Cannabis Sales by Country
  • 3.3.2 North America Pharmaceutical Cannabis Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Pharmaceutical Cannabis Market Facts & Figures by Country
  • 3.4.1 Europe Pharmaceutical Cannabis Sales by Country
  • 3.4.2 Europe Pharmaceutical Cannabis Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Pharmaceutical Cannabis Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Pharmaceutical Cannabis Sales by Region
  • 3.5.2 Asia Pacific Pharmaceutical Cannabis Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Pharmaceutical Cannabis Market Facts & Figures by Country
  • 3.6.1 Latin America Pharmaceutical Cannabis Sales by Country
  • 3.6.2 Latin America Pharmaceutical Cannabis Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Pharmaceutical Cannabis Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Pharmaceutical Cannabis Sales by Country
  • 3.7.2 Middle East and Africa Pharmaceutical Cannabis Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Pharmaceutical Cannabis Historic Market Analysis by Type

• 4.1 Global Pharmaceutical Cannabis Sales Market Share by Type (2016-2021)
• 4.2 Global Pharmaceutical Cannabis Revenue Market Share by Type (2016-2021)
• 4.3 Global Pharmaceutical Cannabis Price by Type (2016-2021)

5 Global Pharmaceutical Cannabis Historic Market Analysis by Application

• 5.1 Global Pharmaceutical Cannabis Sales Market Share by Application (2016-2021)
• 5.2 Global Pharmaceutical Cannabis Revenue Market Share by Application (2016-2021)
• 5.3 Global Pharmaceutical Cannabis Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Canopy Growth Corporation
  • 6.1.1 Canopy Growth Corporation Corporation Information
  • 6.1.2 Canopy Growth Corporation Description and Business Overview
  • 6.1.3 Canopy Growth Corporation Pharmaceutical Cannabis Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Canopy Growth Corporation Pharmaceutical Cannabis Product Portfolio
  • 6.1.5 Canopy Growth Corporation Recent Developments/Updates
• 6.2 GW Pharmaceuticals, plc
  • 6.2.1 GW Pharmaceuticals, plc Corporation Information
  • 6.2.2 GW Pharmaceuticals, plc Description and Business Overview
  • 6.2.3 GW Pharmaceuticals, plc Pharmaceutical Cannabis Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 GW Pharmaceuticals, plc Pharmaceutical Cannabis Product Portfolio
  • 6.2.5 GW Pharmaceuticals, plc Recent Developments/Updates
• 6.3 Aurora Cannabis, Inc.
  • 6.3.1 Aurora Cannabis, Inc. Corporation Information
  • 6.3.2 Aurora Cannabis, Inc. Description and Business Overview
  • 6.3.3 Aurora Cannabis, Inc. Pharmaceutical Cannabis Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Aurora Cannabis, Inc. Pharmaceutical Cannabis Product Portfolio
  • 6.3.5 Aurora Cannabis, Inc. Recent Developments/Updates
• 6.4 Aphria, Inc.
  • 6.4.1 Aphria, Inc. Corporation Information
  • 6.4.2 Aphria, Inc. Description and Business Overview
  • 6.4.3 Aphria, Inc. Pharmaceutical Cannabis Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Aphria, Inc. Pharmaceutical Cannabis Product Portfolio
  • 6.4.5 Aphria, Inc. Recent Developments/Updates
• 6.5 MedReleaf Corporation
  • 6.5.1 MedReleaf Corporation Corporation Information
  • 6.5.2 MedReleaf Corporation Description and Business Overview
  • 6.5.3 MedReleaf Corporation Pharmaceutical Cannabis Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 MedReleaf Corporation Pharmaceutical Cannabis Product Portfolio
  • 6.5.5 MedReleaf Corporation Recent Developments/Updates
• 6.6 Insys Therapeutics, Inc.
  • 6.6.1 Insys Therapeutics, Inc. Corporation Information
  • 6.6.2 Insys Therapeutics, Inc. Description and Business Overview
  • 6.6.3 Insys Therapeutics, Inc. Pharmaceutical Cannabis Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Insys Therapeutics, Inc. Pharmaceutical Cannabis Product Portfolio
  • 6.6.5 Insys Therapeutics, Inc. Recent Developments/Updates
• 6.7 CanniMed Therapeutics, Inc.
  • 6.6.1 CanniMed Therapeutics, Inc. Corporation Information
  • 6.6.2 CanniMed Therapeutics, Inc. Description and Business Overview
  • 6.6.3 CanniMed Therapeutics, Inc. Pharmaceutical Cannabis Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 CanniMed Therapeutics, Inc. Pharmaceutical Cannabis Product Portfolio
  • 6.7.5 CanniMed Therapeutics, Inc. Recent Developments/Updates
• 6.8 Cara Therapeutics, Inc.
  • 6.8.1 Cara Therapeutics, Inc. Corporation Information
  • 6.8.2 Cara Therapeutics, Inc. Description and Business Overview
  • 6.8.3 Cara Therapeutics, Inc. Pharmaceutical Cannabis Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Cara Therapeutics, Inc. Pharmaceutical Cannabis Product Portfolio
  • 6.8.5 Cara Therapeutics, Inc. Recent Developments/Updates
• 6.9 United Cannabis Corporation
  • 6.9.1 United Cannabis Corporation Corporation Information
  • 6.9.2 United Cannabis Corporation Description and Business Overview
  • 6.9.3 United Cannabis Corporation Pharmaceutical Cannabis Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 United Cannabis Corporation Pharmaceutical Cannabis Product Portfolio
  • 6.9.5 United Cannabis Corporation Recent Developments/Updates

7 Pharmaceutical Cannabis Manufacturing Cost Analysis

• 7.1 Pharmaceutical Cannabis Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Pharmaceutical Cannabis
• 7.4 Pharmaceutical Cannabis Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Pharmaceutical Cannabis Distributors List
• 8.3 Pharmaceutical Cannabis Customers

9 Pharmaceutical Cannabis Market Dynamics

• 9.1 Pharmaceutical Cannabis Industry Trends
• 9.2 Pharmaceutical Cannabis Growth Drivers
• 9.3 Pharmaceutical Cannabis Market Challenges
• 9.4 Pharmaceutical Cannabis Market Restraints

10 Global Market Forecast

• 10.1 Pharmaceutical Cannabis Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Pharmaceutical Cannabis by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Pharmaceutical Cannabis by Type (2022-2027)
• 10.2 Pharmaceutical Cannabis Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Pharmaceutical Cannabis by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Pharmaceutical Cannabis by Application (2022-2027)
• 10.3 Pharmaceutical Cannabis Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Pharmaceutical Cannabis by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Pharmaceutical Cannabis by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
THC-dominant
CBD-dominant
Balanced THC & CBD

Segment by Application
Cancer
Arthritis
Migraine
Epilepsy
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Canopy Growth Corporation
GW Pharmaceuticals, plc
Aurora Cannabis, Inc.
Aphria, Inc.
MedReleaf Corporation
Insys Therapeutics, Inc.
CanniMed Therapeutics, Inc.
Cara Therapeutics, Inc.
United Cannabis Corporation